Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$17.32
-6.7%
$27.43
$13.74
▼
$40.99
$4.05B2.5322.18 million shs3.23 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$40.45
-2.8%
$39.99
$35.12
▼
$64.16
$180.98B0.716.27 million shs4.87 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.02%-19.04%-33.97%-32.41%-50.02%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-0.14%+0.48%+7.28%-9.00%-13.74%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$17.32
-6.7%
$27.43
$13.74
▼
$40.99
$4.05B2.5322.18 million shs3.23 million shs
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$40.45
-2.8%
$39.99
$35.12
▼
$64.16
$180.98B0.716.27 million shs4.87 million shs
Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
-6.02%-19.04%-33.97%-32.41%-50.02%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
-0.14%+0.48%+7.28%-9.00%-13.74%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2.13
Hold$31.5382.07% Upside
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
2.00
Hold$59.4446.94% Upside

Current Analyst Ratings Breakdown

Latest NVO and HIMS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetHold$31.00 ➝ $24.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetEqual Weight$28.00 ➝ $25.00
11/10/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Lower Price TargetBuy$42.00 ➝ $32.00
11/4/2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
Reiterated RatingSell (D)
10/12/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Set Price TargetMarket Perform$47.00 ➝ $40.00
10/9/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingNeutral
10/8/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
DowngradeHold (C-) ➝ Sell (D+)
9/29/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingMarket Perform
9/29/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingSell
9/22/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
DowngradeHold ➝ Sell$38.00
9/21/2026
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
Reiterated RatingNeutral
(Data available from 11/17/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$2.35B1.72$0.73 per share23.58$1.52 per share11.39
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$46.80B3.86$4.67 per share8.67$7.51 per share5.39
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$128.37M-$0.83N/A577.30N/A-6.65%-9.62%-1.38%N/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$15.51B$3.9710.2111.721.4033.99%53.52%19.49%2/3/2027 (Estimated)

Latest NVO and HIMS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
$0.0563$0.0280-$0.0283-$0.14$893.13 million$890.37 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
N/AN/AN/AN/AN/A
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
$0.822.03%+21.74%20.65%N/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
3.85
0.92
0.87
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.54
0.84
0.64

Institutional Ownership

CompanyInstitutional Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
63.52%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
11.54%

Insider Ownership

CompanyInsider Ownership
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
11.76%
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
0.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Hims & Hers Health, Inc. stock logo
HIMS
Hims & Hers Health
2,442233.31 million206.85 millionOptionable
Novo Nordisk A/S stock logo
NVO
Novo Nordisk A/S
69,5054.47 billion4.46 billionOptionable

Recent News About These Companies

Novo Nordisk Stock Rises on Obesity Drug Breakthrough
Novo Nordisk Stock in Focus as New Obesity Drug Shows Promise
Novo Nordisk reports additional CagriSema weight-loss findings
Novo Nordisk A/S (NYSE:NVO) Stock Now Rated "Hold" by Sell-Side Analysts
Novo Nordisk's Pipeline Momentum Meets a Harder Earnings Test

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Hims & Hers Health stock logo

Hims & Hers Health NYSE:HIMS

$17.32 -1.24 (-6.69%)
As of 10:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Novo Nordisk A/S stock logo

Novo Nordisk A/S NYSE:NVO

$40.45 -1.15 (-2.76%)
As of 10:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.